Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation
Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an impla...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Eun, Seok-chan [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
4 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study - Reyaz, Saima ELSEVIER, 2021, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:91 ; year:2016 ; pages:124-127 ; extent:4 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijporl.2016.10.023 |
|---|
| Katalog-ID: |
ELV029563127 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV029563127 | ||
| 003 | DE-627 | ||
| 005 | 20230623201756.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijporl.2016.10.023 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016005000019.pica |
| 035 | |a (DE-627)ELV029563127 | ||
| 035 | |a (ELSEVIER)S0165-5876(16)30369-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 540 |a 004 |q VZ |
| 084 | |a 35.06 |2 bkl | ||
| 100 | 1 | |a Eun, Seok-chan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation |
| 264 | 1 | |c 2016 | |
| 300 | |a 4 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems. | ||
| 650 | 7 | |a Device exposure |2 Elsevier | |
| 650 | 7 | |a Cochlear implant |2 Elsevier | |
| 650 | 7 | |a Temporalis myofascial flap |2 Elsevier | |
| 650 | 7 | |a Complication |2 Elsevier | |
| 700 | 1 | |a Kim, So Young |4 oth | |
| 700 | 1 | |a Kim, Chong Sun |4 oth | |
| 700 | 1 | |a Koo, Ja-Won |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Reyaz, Saima ELSEVIER |t Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |d 2021 |g Amsterdam [u.a.] |w (DE-627)ELV006862241 |
| 773 | 1 | 8 | |g volume:91 |g year:2016 |g pages:124-127 |g extent:4 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijporl.2016.10.023 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.06 |j Computeranwendungen |x Chemie |q VZ |
| 951 | |a AR | ||
| 952 | |d 91 |j 2016 |h 124-127 |g 4 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
s c e sce |
|---|---|
| matchkey_str |
eunseokchankimsoyoungkimchongsunkoojawon:2016----:eprlsyfsillpoeaeoetuinfnenleief |
| hierarchy_sort_str |
2016 |
| bklnumber |
35.06 |
| publishDate |
2016 |
| allfields |
10.1016/j.ijporl.2016.10.023 doi GBVA2016005000019.pica (DE-627)ELV029563127 (ELSEVIER)S0165-5876(16)30369-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 004 VZ 35.06 bkl Eun, Seok-chan verfasserin aut Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation 2016 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems. Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication Elsevier Kim, So Young oth Kim, Chong Sun oth Koo, Ja-Won oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:91 year:2016 pages:124-127 extent:4 https://doi.org/10.1016/j.ijporl.2016.10.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 91 2016 124-127 4 045F 610 |
| spelling |
10.1016/j.ijporl.2016.10.023 doi GBVA2016005000019.pica (DE-627)ELV029563127 (ELSEVIER)S0165-5876(16)30369-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 004 VZ 35.06 bkl Eun, Seok-chan verfasserin aut Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation 2016 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems. Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication Elsevier Kim, So Young oth Kim, Chong Sun oth Koo, Ja-Won oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:91 year:2016 pages:124-127 extent:4 https://doi.org/10.1016/j.ijporl.2016.10.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 91 2016 124-127 4 045F 610 |
| allfields_unstemmed |
10.1016/j.ijporl.2016.10.023 doi GBVA2016005000019.pica (DE-627)ELV029563127 (ELSEVIER)S0165-5876(16)30369-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 004 VZ 35.06 bkl Eun, Seok-chan verfasserin aut Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation 2016 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems. Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication Elsevier Kim, So Young oth Kim, Chong Sun oth Koo, Ja-Won oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:91 year:2016 pages:124-127 extent:4 https://doi.org/10.1016/j.ijporl.2016.10.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 91 2016 124-127 4 045F 610 |
| allfieldsGer |
10.1016/j.ijporl.2016.10.023 doi GBVA2016005000019.pica (DE-627)ELV029563127 (ELSEVIER)S0165-5876(16)30369-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 004 VZ 35.06 bkl Eun, Seok-chan verfasserin aut Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation 2016 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems. Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication Elsevier Kim, So Young oth Kim, Chong Sun oth Koo, Ja-Won oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:91 year:2016 pages:124-127 extent:4 https://doi.org/10.1016/j.ijporl.2016.10.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 91 2016 124-127 4 045F 610 |
| allfieldsSound |
10.1016/j.ijporl.2016.10.023 doi GBVA2016005000019.pica (DE-627)ELV029563127 (ELSEVIER)S0165-5876(16)30369-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 004 VZ 35.06 bkl Eun, Seok-chan verfasserin aut Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation 2016 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems. Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication Elsevier Kim, So Young oth Kim, Chong Sun oth Koo, Ja-Won oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:91 year:2016 pages:124-127 extent:4 https://doi.org/10.1016/j.ijporl.2016.10.023 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 91 2016 124-127 4 045F 610 |
| language |
English |
| source |
Enthalten in Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study Amsterdam [u.a.] volume:91 year:2016 pages:124-127 extent:4 |
| sourceStr |
Enthalten in Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study Amsterdam [u.a.] volume:91 year:2016 pages:124-127 extent:4 |
| format_phy_str_mv |
Article |
| bklname |
Computeranwendungen |
| institution |
findex.gbv.de |
| topic_facet |
Device exposure Cochlear implant Temporalis myofascial flap Complication |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| authorswithroles_txt_mv |
Eun, Seok-chan @@aut@@ Kim, So Young @@oth@@ Kim, Chong Sun @@oth@@ Koo, Ja-Won @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV006862241 |
| dewey-sort |
3610 |
| id |
ELV029563127 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029563127</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623201756.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijporl.2016.10.023</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016005000019.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029563127</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-5876(16)30369-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">004</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.06</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Eun, Seok-chan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Device exposure</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cochlear implant</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Temporalis myofascial flap</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Complication</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, So Young</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Chong Sun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koo, Ja-Won</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Reyaz, Saima ELSEVIER</subfield><subfield code="t">Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV006862241</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:91</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:124-127</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijporl.2016.10.023</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.06</subfield><subfield code="j">Computeranwendungen</subfield><subfield code="x">Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">91</subfield><subfield code="j">2016</subfield><subfield code="h">124-127</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Eun, Seok-chan |
| spellingShingle |
Eun, Seok-chan ddc 610 ddc 540 bkl 35.06 Elsevier Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation |
| authorStr |
Eun, Seok-chan |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV006862241 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences 004 - Data processing & computer science |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 540 004 VZ 35.06 bkl Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication Elsevier |
| topic |
ddc 610 ddc 540 bkl 35.06 Elsevier Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication |
| topic_unstemmed |
ddc 610 ddc 540 bkl 35.06 Elsevier Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication |
| topic_browse |
ddc 610 ddc 540 bkl 35.06 Elsevier Device exposure Elsevier Cochlear implant Elsevier Temporalis myofascial flap Elsevier Complication |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s y k sy syk c s k cs csk j w k jwk |
| hierarchy_parent_title |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| hierarchy_parent_id |
ELV006862241 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry 000 - Computer science, knowledge & systems |
| hierarchy_top_title |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV006862241 |
| title |
Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation |
| ctrlnum |
(DE-627)ELV029563127 (ELSEVIER)S0165-5876(16)30369-X |
| title_full |
Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation |
| author_sort |
Eun, Seok-chan |
| journal |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| journalStr |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science 000 - Computer science, information & general works |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
124 |
| author_browse |
Eun, Seok-chan |
| container_volume |
91 |
| physical |
4 |
| class |
610 610 DE-600 540 004 VZ 35.06 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Eun, Seok-chan |
| doi_str_mv |
10.1016/j.ijporl.2016.10.023 |
| dewey-full |
610 540 004 |
| title_sort |
temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation |
| title_auth |
Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation |
| abstract |
Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems. |
| abstractGer |
Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems. |
| abstract_unstemmed |
Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation |
| url |
https://doi.org/10.1016/j.ijporl.2016.10.023 |
| remote_bool |
true |
| author2 |
Kim, So Young Kim, Chong Sun Koo, Ja-Won |
| author2Str |
Kim, So Young Kim, Chong Sun Koo, Ja-Won |
| ppnlink |
ELV006862241 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.ijporl.2016.10.023 |
| up_date |
2024-07-06T21:46:54.704Z |
| _version_ |
1803867824801710080 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029563127</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623201756.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijporl.2016.10.023</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016005000019.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029563127</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-5876(16)30369-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">004</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.06</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Eun, Seok-chan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Temporalis myofascial flap coverage for extrusion of internal device after cochlear implantation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Two pediatric patients with internal device exposure of cochlear implant (CI) were treated successfully using vascularized temporalis myofascial flaps. The visible scarring was minimal, and the CI function was excellent. Although we used temporalis myofascial flaps for late complications of an implanted ear, it can also be used in a primary case to provide flap reinforcement. In conclusion, the temporalis myofascial flap technique is an ultimate surgical option that offers advantages for CI patients with flap-related problems.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Device exposure</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cochlear implant</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Temporalis myofascial flap</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Complication</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, So Young</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Chong Sun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koo, Ja-Won</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Reyaz, Saima ELSEVIER</subfield><subfield code="t">Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV006862241</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:91</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:124-127</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijporl.2016.10.023</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.06</subfield><subfield code="j">Computeranwendungen</subfield><subfield code="x">Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">91</subfield><subfield code="j">2016</subfield><subfield code="h">124-127</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400342 |